LianBio
LIANY · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6 | $9 | $9 | $11 |
| G&A Expenses | $0 | $17 | $16 | $15 |
| SG&A Expenses | $16 | $17 | $15 | $15 |
| Sales & Mktg Exp. | $0 | $0 | -$0 | $0 |
| Other Operating Expenses | -$0 | $0 | $1 | $0 |
| Operating Expenses | $22 | $26 | $24 | $26 |
| Operating Income | -$22 | -$26 | -$25 | -$26 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $405 | $3 | $4 | $2 |
| Pre-Tax Income | $383 | -$23 | -$21 | -$24 |
| Tax Expense | -$1 | $1 | $0 | $0 |
| Net Income | $384 | -$24 | -$22 | -$24 |
| % Margin | – | – | – | – |
| EPS | 3.56 | -0.22 | -0.2 | -0.22 |
| % Growth | 1,718.2% | -10% | 9.1% | – |
| EPS Diluted | 3.55 | -0.22 | -0.2 | -0.22 |
| Weighted Avg Shares Out | 108 | 107 | 107 | 107 |
| Weighted Avg Shares Out Dil | 108 | 107 | 107 | 107 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $3 | $3 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $383 | -$23 | -$25 | -$23 |
| % Margin | – | – | – | – |